Supply of anti-cancer drugs, immunosuppressants, and immunoglobulins
Tender for the supply of essential medicines including anti-cancer drugs, immunosuppressants, and immunoglobulins, divided into 19 lots, to serve the regional hospital.
CONTRACTING AUTHORITY
Name
Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej
City
Biała Podlaska
Country
PL
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33652100 – Antineoplastic agents.
Other CPV
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
33652300 – Immunosuppressive agents.
33651520 – Immunoglobulins.
LOTS (19)
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Krebsmedikamente
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunsuppressiva
Immunoglobuline
Immunoglobuline
Immunsuppressiva
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
Yes
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
17 days remaining(LOT-0001)
Published